Read more
1:39 PM · 11 November 2025

TSMC reports the lowest revenue growth in more than a year 📊

TSMC
Stocks
TSM.US, Taiwan Semiconductor Manufacuring Company Ltd - ADR
-
-

TSMC (Taiwan Semiconductor Manufacturing, TSM.US) — the main producer of AI chips and Nvidia’s largest manufacturing partner — reported its slowest monthly revenue growth in over a year. October sales rose 16.9% year-over-year, in line with analysts’ expectations.

  • The strength of the local currency likely weighed on reported figures in Taiwanese dollars, although in U.S. dollar terms, sales rose 22.6% to $12 billion, up from $9.8 billion a year earlier. The result does not indicate weaker demand for AI chips; rather, the data were distorted by earlier orders and a weaker dollar. TSMC shares traded mostly flat in Tuesday’s Asian session, while industry players maintain a positive outlook for AI-driven growth.
  • TSMC continues to face record-high demand for its latest N3 chips, as AI giants Nvidia, Apple, Amazon, Meta, and Microsoft compete for limited production capacity. According to a recent JPMorgan report, Nvidia requested production be raised to 160,000 wafers per month, but TSMC is unlikely to exceed 140,000–145,000 wafers by the end of 2026.
  • This implies that chip shortages could persist for at least two more years. The strong AI-related demand has pushed TSMC’s fabs to full capacity, boosting its gross margins, which the market estimates could reach 60–65% in the first half of 2026.

TSMC’s largest clients have reserved production slots well in advance, meaning smaller firms — such as crypto miners — may have limited access to chips. Instead of building a new N3 plant, TSMC is upgrading existing facilities:

  • Fab 18 in Tainan will expand output by 25,000 wafers per month,

  • Fab 20 (Hsinchu) and Fab 22 (Kaohsiung) are being prepared for N2 and A16 technologies.
    The company also plans to utilize older N6 and N7 lines, potentially adding 5,000–10,000 wafers per month by late 2026.
    In the U.S., Fab 21 in Arizona will enter its second phase in mid-2026, but full production (10,000 wafers/month) is expected only in 2027 — too late to ease the current supply shortage.

According to market sources, some clients are paying up to twice the standard rate (so-called hot-run premiums) to secure priority access. Roughly 10% of total production now operates under this scheme, further boosting TSMC’s profits. Analysts estimate that planned price increases of 6–10% in 2026 will allow the company to maintain gross margins above 60%, with results likely exceeding market expectations. The company reports revenue on a monthly basis.

TSMC shares (D1 interval)

The stock recently dipped below the 50-day EMA but quickly recovered. For bulls, regaining the $300 level per share would strengthen the case for a move toward record highs. Although October revenue came in slightly below the recent growth trend, this was likely driven by seasonal and one-off factors rather than operational weakness. The company’s fabs are running at full capacity, and high-margin semiconductors continue to make up an increasing share of total sales.

Source: xStation5

24 November 2025, 6:34 PM

Omnicom and Interpublic Join Forces. Will the Merger Be Enough to Catch Up with Big Tech?

24 November 2025, 5:23 PM

Has Alphabet just won the AI race?

21 November 2025, 9:31 PM

MicroStrategy in trouble? Shares down 67% from the highs ✂

21 November 2025, 7:43 PM

Stock of the Week – NVIDIA (21.11.2025)

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.

Join over 2 000 000 investors from around the world

The financial instruments we offer, especially CFDs, can be highly risky. Please consider if you understand the risks and can afford the loss of capital. XTB is regulated by the SCA

The financial instruments we offer, especially CFDs, can be highly risky. Please consider if you understand the risks and can afford the loss of capital. XTB is regulated by the SCA

The financial instruments we offer are risky. XTB is regulated by the DFSA.